πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 14 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9801874

Method for the preparation of liposome encapsulated vincristine for therapeutic use

Tekmira Pharmaceuticals Corporation Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9345780

Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic

Tekmira Pharmaceuticals Corporation Β· Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9220683

Lipids and compositions for the delivery of therapeutics

Tekmira Pharmaceuticals Corporation Β· Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9186325

Lipids and compositions for the delivery of therapeutics

Tekmira Pharmaceuticals Corporation Β· Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9139554

Amino lipids and methods for the delivery of nucleic acids

Tekmira Pharmaceuticals Corporation Β· Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9051567

Methods for increasing efficacy of lipid formulated siRNA

Tekmira Pharmaceuticals Corporation Β· Granted Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8999351

Lipids and compositions for the delivery of therapeutics

Tekmira Pharmaceuticals Corporation Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8883202

Lipid compositions

Tekmira Pharmaceuticals Corporation Β· Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8802644

Lipid formulation

Tekmira Pharmaceuticals Corporation Β· Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8722082

Lipids and compositions for the delivery of therapeutics

Tekmira Pharmaceuticals Corporation Β· Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8642076

Lipid containing formulations

Tekmira Pharmaceuticals Corporation Β· Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8575123

Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic

Tekmira Pharmaceuticals Corporation Β· Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7811602

Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof

Tekmira Pharmaceuticals Corporation Β· Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7244448

Liposomal antineoplastic drugs and uses thereof

Tekmira Pharmaceuticals Corporation Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted